Delayed rabies post-exposure prophylaxis treatment among Dutch travellers during their stay abroad: a comprehensive analysis

被引:6
|
作者
Verdoes, Loes [1 ]
Luppino, Floriana S. [2 ]
Wallinga, Jacco [3 ]
Visser, Leo G. [4 ]
机构
[1] The Hague Univ Appl Sci, Nursing Educ, The Hague, Netherlands
[2] Eurocross Assistance, Leiden, Netherlands
[3] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands
[4] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands
关键词
Rabies vaccines; rabies immunoglobulin; animal bite; treatment delay; PrEP; PEP; travel destination; RISK; VACCINATION;
D O I
10.1093/jtm/taaa240
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: After an animal-associated injury (AAI) in rabies-endemic regions, post-exposure prophylaxis (PEP) is needed to prevent infection.(1,2) PEP consists of rabies vaccinations (RV) and in some cases also additional rabies immune globulins (RIG). Not always PEP medication, and RIG in particular, is accessible. Along with an increased number of exposure notifications among Dutch travellers, this might lead to treatment delay and thus to increased health risks. Until now, research mainly focused on factors associated with exposition, but none on which factors are associated with PEP delay. This study aimed to identify which general sample characteristics are associated with PEP delay while being abroad. Methods: A quantitative retrospective observational study was conducted. The study population consisted of insured Dutch international travellers who actively contacted their medical assistance company (2015-2019) because of an animal-associated injury (AAI) (N = 691). The association between general sample characteristics and delay of different PEP treatments was studied using survival analysis. Results: Travellers without pre-exposure prophylaxis (PrEP) had an increased hazard, and therefore a shorter delay, for receiving their first RV as compared to travellers with PrEP (HR:1.11, 95%CI:1.01-1.22). The travellers needing both RV and RIG had a decreased hazard, and therefore a longer delay, as compared to travellers only needing RV (HR:0.81, 95%CI:0.67-0.96). General sample characteristic associated with RIG administration delay was travel destination. Travellers to Central and South America, East Mediterranean and Europe had a decreased hazard, and therefore a longer delay, for receiving RIG treatments relative to travellers to South East Asia (HR:0.31, 95%CI:0.130.70; HR:0.34, 95%CI:0.19-0.61; HR:0.46, 95%CI:0.24-0.89; HR:0.48, 95%CI:0.12-0.81, respectively). Conclusions: Our results suggest that the advice for PrEP should be given based on travel destination, as this was found to be the main factor for PEP delay, among travellers going to rabies-endemic countries.
引用
收藏
页数:8
相关论文
共 41 条
  • [1] Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis
    Gautret, Philippe
    Angelo, Kristina M.
    Asgeirsson, Hilmir
    Lalloo, David G.
    Shaw, Marc
    Schwartz, Eli
    Libman, Michael
    Kain, Kevin C.
    Piyaphanee, Watcharapong
    Murphy, Holly
    Leder, Karin
    Vincelette, Jean
    Jensenius, Mogens
    Waggoner, Jesse
    Leung, Daniel
    Borwein, Sarah
    Blumberg, Lucille
    Schlagenhauf, Patricia
    Barnett, Elizabeth D.
    Hamer, Davidson H.
    PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (11):
  • [2] Analysis of qualification for post-exposure prophylaxis against rabies in children in Poland
    Ostrowska, Aleksandra
    Suslo, Anna
    Zablocka, Katarzyna
    Bienkowski, Carlo
    Pokorska-Spiewak, Maria
    PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2022, 42 (3-4) : 142 - 147
  • [3] Rabies post-exposure prophylaxis in travellers returning from Bali, Indonesia, November 2008 to March 2010
    Gautret, P.
    Lim, P. L.
    Shaw, M.
    Leder, K.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (03) : 445 - 447
  • [4] A descriptive analysis of rabies post-exposure prophylaxis data: 2013, Ontario, Canada
    Middleton, D.
    Edwin, J. J.
    Johnson, K. O.
    Warshawsky, B. F.
    ZOONOSES AND PUBLIC HEALTH, 2018, 65 (01) : E66 - E78
  • [5] Rabies post-exposure prophylaxis of international travellers-Results from two major German travel clinics
    Saffar, Farah
    Heinemann, Melina
    Heitkamp, Christian
    Stelzl, Daniel Robert
    Ramharter, Michael
    Schunk, Mirjam
    Rothe, Camilla
    Buehler, Silja
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2023, 53
  • [6] Rabies post-exposure prophylaxis initiation and adherence among patients in Vietnam, 2014-2016
    Tran, Cuc H.
    Afriyie, Doris O.
    Pham, Thach N.
    Otsu, Satoko
    Urabe, Maho
    Dang, Anh D.
    Tran, Huong G. T.
    Nguyen, Hoang, V
    Le, Ha T.
    Nguyen, Huong T. T.
    VACCINE, 2019, 37 : A54 - A63
  • [7] Evaluating the benefit of serology during potential Australian bat lyssavirus and rabies post-exposure prophylaxis
    Harris, James
    Uren, Alexandra
    Smith, James
    Titmus, Emily
    Young, Megan
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2023, 47 (06)
  • [8] IMMUNE RESPONSE AND COST ANALYSIS OF INTRADERMAL RABIES VACCINATION FOR POST-EXPOSURE PROPHYLAXIS REGIMEN IN HUMAN
    Budayanti, N. S.
    Susilawathi, N. M.
    Darwinata, A. E.
    Dwija, I. B. P.
    Fatmawati, N. D.
    Wirasandhi, K.
    Subrata, K.
    Susilarini, N. K.
    Wignall, F. S.
    Sudewi, A. A. R.
    Mahardika, G. N. K.
    BALI MEDICAL JOURNAL, 2014, 3 (01) : 18 - 24
  • [9] A retrospective descriptive analysis of rabies post-exposure prophylaxis cases in Dalian from 2016 to 2017
    Song, Yi
    Lu, Xiaoguang
    Jiang, Xue
    Zhao, Weitong
    Fan, Zhiwei
    Kang, Xin
    Wang, Yu
    EPIDEMIOLOGY AND INFECTION, 2019, 147
  • [10] Rabies post-exposure prophylaxis: A retrospective analysis of timing of initiation and antibody responses in a Belgian cohort
    Hens, Matilde
    Declercq, Steven
    Berens-Riha, Nicole
    Maniewski, Ula
    Theunissen, Caroline
    van den Broucke, Steven
    De Bievre, Felix
    Brosius, Isabel
    Liesenborghs, Laurens
    Van Dijck, Christophe
    Burm, Christophe
    Nauwelaers, Inne
    Balliauw, Katleen
    Visser, Benjamin J.
    Bottieau, Emmanuel
    Soentjens, Patrick
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2024, 62